InvestorsHub Logo
Followers 105
Posts 4947
Boards Moderated 0
Alias Born 10/20/2015

Re: bwolfy2002 post# 186151

Sunday, 09/26/2021 2:10:57 AM

Sunday, September 26, 2021 2:10:57 AM

Post# of 232869
LZ is an interesting drug for research but it is not a viable drug to commercialize because the Company that sponsors it has no ability to produce the drug in commercial quantities. CytoDyn has enough already produced drug to begin shipping commercial quantities and Samsung can produce much more currently and Samsung is also expanding their production capacity three fold currently. Samsung will be ready to ramp up production considerably in 6 to 12 months. Plans are being layed and ground has already been broken on a super modern new Samsung biologics.
production facility.
CytoDyn has capability to produce LL through Samsung in the initial quantities needed to gain market share.
That and as you pointed out LZ trials met meaningless endpoints.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News